Chugai Pharmaceutical Co., Ltd. CHGCF
OTC PK
| 06/30/2025 | 06/30/2025 | 03/31/2025 | |||
|---|---|---|---|---|---|
| Net Income | -205.52% | -205.52% | 6.27% | ||
| Total Depreciation and Amortization | -- | -- | -- | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 47.44% | 47.44% | 46.50% | ||
| Change in Net Operating Assets | 553.88% | 553.88% | -75.10% | ||
| Cash from Operations | 88.96% | 88.96% | -56.22% | ||
| Capital Expenditure | -28.06% | -28.06% | -11,500.25% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 55.84% | 55.84% | -290.85% | ||
| Cash from Investing | 43.43% | 43.43% | -414.39% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | 200.00% | 200.00% | -133.39% | ||
| Issuance of Common Stock | -90.43% | -90.43% | 618.75% | ||
| Repurchase of Common Stock | 0.00% | 0.00% | 0.00% | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | 99.51% | 99.51% | -32,132.10% | ||
| Other Financing Activities | -7,880.39% | -7,880.39% | 99.35% | ||
| Cash from Financing | 97.27% | 97.27% | -4,599.40% | ||
| Foreign Exchange rate Adjustments | 392.02% | 392.02% | -142.97% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 166.56% | 166.56% | -185.78% | ||